Hologic reported on Wednesday first quarter earnings that matched analysts' forecasts and revenue that topped expectations.
Hologic announced earnings per share of $0.61 on revenue of $850.5M. Analysts polled by anticipated EPS of $0.61 on revenue of $845.09M. That with comparison to EPS of $0.58 on revenue of $830.7M in the same period a year before. Hologic had reported EPS of $0.65 on revenue of $865.8M in the previous quarter. Analysts are expecting EPS of $0.63 and revenue of $852.46M in the upcoming quarter.
Hologic shares are up 4.67% from the beginning of the year and are trading at $54.65 , still down 0.91% from its 52 week high of $55.15 set on January 29. They are outperforming the Nasdaq which is up 2.61% year to date.
Hologic follows other major Healthcare sector earnings this month
Hologic's report follows an earnings beat by J&J on January 22, who reported EPS of $1.88 on revenue of $20.75B, compared to forecasts EPS of $1.87 on revenue of $20.8B.
Novartis ADR had beat expectations on Wednesday with fourth quarter EPS of $1.32 on revenue of $12.4B, compared to forecast for EPS of $1.31 on revenue of $12.33B.
Stay up-to-date on all of the upcoming earnings reports by visiting 's earnings calendar
